Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 19-20/2013

01.10.2013 | main topic

Stress ulcer prophylaxis, thromboprophylaxis and coagulation management in patients with hip fractures

verfasst von: Heinrich Wolfgang Thaler, MD, Peter Dovjak, MD, Prof. Bernhard Iglseder, MD, Georg Pinter, MD, Ernst Müller, MD, Walter Müller, MD, Katharina Pils, MD, Peter Mikosch, MD, Inge Gerstorfer, MD, Michaela Zmaritz, Prof. Monique Weissenberger-Leduc, MD, Markus Gosch, MD

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 19-20/2013

Einloggen, um Zugang zu erhalten

Summary

Hip fracture in older patients is a major health concern. 20–25 % of hip fracture patients will die in the first year after the trauma (Lane, Clin Orthop Relat Res 471(8):2711, 2013). Postoperative venous thrombosis and gastrointestinal stress-ulcer bleeding are frequent complications with a high case-fatality rate particularly in older patients. Thromboprophylaxis and stress ulcer prophylaxis are important and well established measures to decrease postoperative complications and the mortality rate in this high-risk population.
The working group on orthogeriatrics of the Austrian Society on Geriatrics and Gerontology (ÖGGG) is composed of geriatricians who work as trauma surgeons, internists, anaestesists and nurses. A thorough literature search was done, using the terms “orthogeriatrics” and “hip fracture” in combination with “stress ulcer”, “gastrointestinal bleeding” and “thrombosis”, “thromboprophylaxis”. The data was collected, discussed and evaluated in several adjustment meetings of the group and summarized in this article.
Literatur
1.
Zurück zum Zitat Issa IA, Soubra O, Nakkash H, Soubra L. Variables associated with stress ulcer prophylaxis misuse: a retrospective analysis. Dig Dis Sci. 2012;57:2633–41.PubMedCrossRef Issa IA, Soubra O, Nakkash H, Soubra L. Variables associated with stress ulcer prophylaxis misuse: a retrospective analysis. Dig Dis Sci. 2012;57:2633–41.PubMedCrossRef
2.
Zurück zum Zitat Monnig AA, Prittie JE. A review of stress-related mucosal disease. J Vet Emerg Crit Care (San Antonio). 2011;21:484–95.CrossRef Monnig AA, Prittie JE. A review of stress-related mucosal disease. J Vet Emerg Crit Care (San Antonio). 2011;21:484–95.CrossRef
3.
Zurück zum Zitat Alhazzani W, Alshahrani M, Moayyedi P, Jaeschke R. Stress ulcer prophylaxis in critically ill patients: review of the evidence. Pol Arch Med Wewn. 2012;122:107–14.PubMed Alhazzani W, Alshahrani M, Moayyedi P, Jaeschke R. Stress ulcer prophylaxis in critically ill patients: review of the evidence. Pol Arch Med Wewn. 2012;122:107–14.PubMed
4.
Zurück zum Zitat Pilotto A, Franceschi M, Maggi S, Addante F, Sancarlo D. Optimal management of peptic ulcer disease in the elderly. Drugs Aging. 2010;27:545–58.PubMedCrossRef Pilotto A, Franceschi M, Maggi S, Addante F, Sancarlo D. Optimal management of peptic ulcer disease in the elderly. Drugs Aging. 2010;27:545–58.PubMedCrossRef
5.
Zurück zum Zitat Vaile JH, Sullivan L, Connor D, Bleasel JF. A year of fractures: a snapshot analysis of the logistics, problems and outcomes of a hospital-based fracture liaison service. Osteoporos Int. 2013 (Epub ahead of print). Vaile JH, Sullivan L, Connor D, Bleasel JF. A year of fractures: a snapshot analysis of the logistics, problems and outcomes of a hospital-based fracture liaison service. Osteoporos Int. 2013 (Epub ahead of print).
6.
Zurück zum Zitat Quenot JP, Mentec H, Feihl F, Annane D, Melot C, Vignon P, Brun-Buisson C. Bedside adherence to clinical practice guidelines in the intensive care unit: the tecla study. Intensive Care Med. 2008;34:1393–400.PubMedCrossRef Quenot JP, Mentec H, Feihl F, Annane D, Melot C, Vignon P, Brun-Buisson C. Bedside adherence to clinical practice guidelines in the intensive care unit: the tecla study. Intensive Care Med. 2008;34:1393–400.PubMedCrossRef
7.
Zurück zum Zitat Kim BJ, Park MK, Kim SJ, Kim ER, Min BH, Son HJ, Rhee PL, Kim JJ, Rhee JC, Lee JH. Comparison of scoring systems for the prediction of outcomes in patients with nonvariceal upper gastrointestinal bleeding: a prospective study. Dig Dis Sci. 2009;54:2523–9.PubMedCrossRef Kim BJ, Park MK, Kim SJ, Kim ER, Min BH, Son HJ, Rhee PL, Kim JJ, Rhee JC, Lee JH. Comparison of scoring systems for the prediction of outcomes in patients with nonvariceal upper gastrointestinal bleeding: a prospective study. Dig Dis Sci. 2009;54:2523–9.PubMedCrossRef
8.
Zurück zum Zitat Trawick EP, Yachimski PS. Management of non-variceal upper gastrointestinal tract hemorrhage: Controversies and areas of uncertainty. World J Gastroenterol. 2012;18:1159–65.PubMedCrossRef Trawick EP, Yachimski PS. Management of non-variceal upper gastrointestinal tract hemorrhage: Controversies and areas of uncertainty. World J Gastroenterol. 2012;18:1159–65.PubMedCrossRef
9.
Zurück zum Zitat Ament PW, Dicola DB, James ME. Reducing adverse effects of proton pump inhibitors. Am Fam Physician. 2012;86:66–70.PubMed Ament PW, Dicola DB, James ME. Reducing adverse effects of proton pump inhibitors. Am Fam Physician. 2012;86:66–70.PubMed
10.
Zurück zum Zitat Huang J, Cao Y, Liao C, Wu L, Gao F. Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials. Crit care. 2010;14:R194.PubMedCrossRef Huang J, Cao Y, Liao C, Wu L, Gao F. Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials. Crit care. 2010;14:R194.PubMedCrossRef
11.
Zurück zum Zitat Dworzynski K, Pollit V, Kelsey A, Higgins B, Palmer K. Management of acute upper gastrointestinal bleeding: summary of nice guidance. BMJ. 2012;344:e3412.PubMedCrossRef Dworzynski K, Pollit V, Kelsey A, Higgins B, Palmer K. Management of acute upper gastrointestinal bleeding: summary of nice guidance. BMJ. 2012;344:e3412.PubMedCrossRef
12.
Zurück zum Zitat Roller RE, Iglseder B, Dovjak P, Lechleitner M, Sommeregger U, Benvenuti-Falger U, Otto R, Bohmdorfer B, Gosch M. [Oral anticoagulation and risk of bleeding in elderly patients—the aspect of polypharmacy]. Wien Med Wochenschr. 2010;160:270–5.PubMedCrossRef Roller RE, Iglseder B, Dovjak P, Lechleitner M, Sommeregger U, Benvenuti-Falger U, Otto R, Bohmdorfer B, Gosch M. [Oral anticoagulation and risk of bleeding in elderly patients—the aspect of polypharmacy]. Wien Med Wochenschr. 2010;160:270–5.PubMedCrossRef
13.
Zurück zum Zitat Hull RD, Raskob GE. Prophylaxis of venous thromboembolic disease following hip and knee surgery. J Bone Joint Surg. 1986;68:146–50.PubMed Hull RD, Raskob GE. Prophylaxis of venous thromboembolic disease following hip and knee surgery. J Bone Joint Surg. 1986;68:146–50.PubMed
14.
Zurück zum Zitat Eikelboom JW, Quinlan DJ, Douketis JD. Extended duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet. 2001;358:9–15.PubMedCrossRef Eikelboom JW, Quinlan DJ, Douketis JD. Extended duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet. 2001;358:9–15.PubMedCrossRef
15.
Zurück zum Zitat Rosendaal FR, Van Hycklama Vlieg A, Doggen JM. Venous thrombosis in the elderly. J Thromb Haemost. 2007;5(Suppl. 1):310–7.PubMedCrossRef Rosendaal FR, Van Hycklama Vlieg A, Doggen JM. Venous thrombosis in the elderly. J Thromb Haemost. 2007;5(Suppl. 1):310–7.PubMedCrossRef
16.
Zurück zum Zitat Falck-Ytter Y, Francis CW, Johanson NA, et al., American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(Suppl. 2):e278–325S. Falck-Ytter Y, Francis CW, Johanson NA, et al., American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(Suppl. 2):e278–325S.
17.
Zurück zum Zitat Kearon C, Akl EA, Comerota AJ, et al., American College of Chest Physicians. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(Suppl. 2):e419S–94S.PubMedCrossRef Kearon C, Akl EA, Comerota AJ, et al., American College of Chest Physicians. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(Suppl. 2):e419S–94S.PubMedCrossRef
18.
Zurück zum Zitat Warkentin TE, et al. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost. 2011;9(12):2498–500.PubMedCrossRef Warkentin TE, et al. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost. 2011;9(12):2498–500.PubMedCrossRef
19.
Zurück zum Zitat Thaler HW, Frisee F, Korninger C. Platelet aggregation inhibitors, plateletfunction testing, and blood loss in hip fracture surgery. J Trauma. 2010;69(5):1217–20 (discussion 1221). Thaler HW, Frisee F, Korninger C. Platelet aggregation inhibitors, plateletfunction testing, and blood loss in hip fracture surgery. J Trauma. 2010;69(5):1217–20 (discussion 1221).
21.
Zurück zum Zitat Mohammed R, Pynsent PB. Perioperative bridging anticoagulation therapy in at-risk patients undergoing elective arthroplasty surgery. Am J Orthop (Belle Mead NJ). 2010;39(10):492–4. Mohammed R, Pynsent PB. Perioperative bridging anticoagulation therapy in at-risk patients undergoing elective arthroplasty surgery. Am J Orthop (Belle Mead NJ). 2010;39(10):492–4.
22.
Zurück zum Zitat Weltermann A, Brodmann M, Domanovits H, et al. Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management. Wien Klin Wochenschr. 2012;124:340–7.PubMedCrossRef Weltermann A, Brodmann M, Domanovits H, et al. Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management. Wien Klin Wochenschr. 2012;124:340–7.PubMedCrossRef
24.
Zurück zum Zitat E Kehrel B, F Brodde M. State of the art in platelet function testing. Transfus Med Hemother. 2013 Apr;40(2):73–86.PubMedCrossRef E Kehrel B, F Brodde M. State of the art in platelet function testing. Transfus Med Hemother. 2013 Apr;40(2):73–86.PubMedCrossRef
Metadaten
Titel
Stress ulcer prophylaxis, thromboprophylaxis and coagulation management in patients with hip fractures
verfasst von
Heinrich Wolfgang Thaler, MD
Peter Dovjak, MD
Prof. Bernhard Iglseder, MD
Georg Pinter, MD
Ernst Müller, MD
Walter Müller, MD
Katharina Pils, MD
Peter Mikosch, MD
Inge Gerstorfer, MD
Michaela Zmaritz
Prof. Monique Weissenberger-Leduc, MD
Markus Gosch, MD
Publikationsdatum
01.10.2013
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 19-20/2013
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-013-0234-0

Weitere Artikel der Ausgabe 19-20/2013

Wiener Medizinische Wochenschrift 19-20/2013 Zur Ausgabe